Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Jill M. Ferdinands"'
Autor:
G.K. Balasubramani, Sean Saul, Mary Patricia Nowalk, Donald B. Middleton, Jill M. Ferdinands, Richard K. Zimmerman
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 1, Pp 91-96 (2019)
Purpose: Hospitalized patients with an acute respiratory illness (ARI) were compared to determine if demographic characteristics, timing or influenza vaccination biased who received clinical respiratory viral panel (RVP) testing. Methods: 171 enrolle
Externí odkaz:
https://doaj.org/article/f36612dae5a54583a70177e9fb6ffc47
Autor:
Emily R. Levy, Wai-Ki Yip, Michael Super, Jill M. Ferdinands, Anushay J. Mistry, Margaret M. Newhams, Yu Zhang, Helen C. Su, Gwenn E. McLaughlin, Anil Sapru, Laura L. Loftis, Scott L. Weiss, Mark W. Hall, Natalie Cvijanovich, Adam Schwarz, Keiko M. Tarquinio, Peter M. Mourani, PALISI PICFLU Investigators, Adrienne G. Randolph
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Background: Mannose-binding lectin (MBL) is an innate immune protein with strong biologic plausibility for protecting against influenza virus-related sepsis and bacterial co-infection. In an autopsy cohort of 105 influenza-infected young people, carr
Externí odkaz:
https://doaj.org/article/ecd1e53a62ae49fba1fe032cd62b2463
Publikováno v:
Vaccine: X, Vol 1, Iss , Pp - (2019)
Background: Vaccination history may confound estimates of influenza vaccine effectiveness (VE) when two conditions are present: (1) Influenza vaccination is associated with vaccination history and (2) vaccination modifies the risk of natural infectio
Externí odkaz:
https://doaj.org/article/0cb28cb126e44926b54bb8dca436ad50
Autor:
Jill M. Ferdinands, Amy M. Denison, Nicole F. Dowling, Heather A. Jost, Marta L. Gwinn, Lindy Liu, Sherif R. Zaki, David K. Shay
Publikováno v:
Emerging Infectious Diseases, Vol 17, Iss 12, Pp 2294-2302 (2011)
We compared the prevalence of 8 polymorphisms in the tumor necrosis factor and mannose-binding lectin genes among 105 children and young adults with fatal influenza with US population estimates and determined in subanalyses whether these polymorphism
Externí odkaz:
https://doaj.org/article/fe9dbc60167241dea8ec0cd61ae65c57
Publikováno v:
Epidemiology. 34:345-352
Autor:
Katherine M Begley, Arnold S Monto, Lois E Lamerato, Anurag N Malani, Adam S Lauring, H Keipp Talbot, Manjusha Gaglani, Tresa McNeal, Fernanda P Silveira, Richard K Zimmerman, Donald B Middleton, Shekhar Ghamande, Kempapura Murthy, Lindsay Kim, Jill M Ferdinands, Manish M Patel, Emily T Martin
Publikováno v:
Clinical Infectious Diseases.
Background Current understanding of severe respiratory syncytial virus (RSV) infections in adults is limited by clinical underrecognition. We compared the prevalence, clinical characteristics, and outcomes of RSV infections vs influenza in adults hos
Autor:
Nathaniel M Lewis, Jessie R Chung, Timothy M Uyeki, Lisa Grohskopf, Jill M Ferdinands, Manish M Patel
Publikováno v:
Clinical Infectious Diseases. 75:170-175
Background Relative vaccine effectiveness (rVE) are metrics commonly reported to compare absolute VE (aVE) of 2 vaccine products. Methods Estimates of rVE for enhanced influenza vaccines (eIV) vs standard inactivated influenza vaccine (IIV) have been
Autor:
Rachael M. Porter, I-Chia Liao, Palak Patel, Nimish R Valvi, Duck-Hye Yang, Sue Reynolds, Ned Lewis, Patrick K. Mitchell, Catherine H Bozio, Malini B. DeSilva, Sarah Ball, Manjusha Gaglani, Brian E. Dixon, Kristin Goddard, Toan C Ong, Edward Stenehjem, Kristen A Butterfield, Stephanie A. Irving, Charlene McEvoy, Bruce Fireman, Anupam B Kharbanda, Andrea Steffens, Rebecca J Birch, Nancy Grisel, Peter J Embi, Meredith McMorrow, Julie Arndorfer, Shaun J. Grannis, Jennifer R. Verani, Natalie Olson, Kempapura Murthy, Jill M. Ferdinands, Elizabeth A Rowley, Alicia M. Fry, Jungmi Han, Lenee Blanton, Mark G. Thompson, Eric P Griggs, Chandni Raiyani, Kristin Dascomb, William F. Fadel, Suchitra Rao, Matthew E Levy, Karthik Natarajan, Michelle A Barron, Nicola P. Klein, Eduardo Azziz-Baumgartner, Sarah E Reese, Ousseny Zerbo, Stephanie J. Schrag, Monica Dickerson, Allison L. Naleway, Jeremiah Williams
Publikováno v:
Morbidity and Mortality Weekly Report
Previous infection with SARS-CoV-2 (the virus that causes COVID-19) or COVID-19 vaccination can provide immunity and protection from subsequent SARS-CoV-2 infection and illness. CDC used data from the VISION Network* to examine hospitalizations in ad
Autor:
Katherine M. Begley, Arnold S. Monto, Lois E. Lamerato, Anurag N. Malani, Adam S. Lauring, H. Keipp Talbot, Manjusha Gaglani, Tresa McNeal, Fernanda P. Silveira, Richard K. Zimmerman, Donald B. Middleton, Shekhar Ghamande, Kempapura Murthy, Lindsay Kim, Jill M. Ferdinands, Manish M. Patel, Emily T. Martin
BackgroundRespiratory syncytial virus (RSV) is under-recognized in hospitalized adults. We evaluated severity of acute respiratory illness (ARI) including intensive care unit (ICU) admission and mechanical ventilation in a national surveillance netwo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da31195b24cde73db01606bdf2108bb9
https://doi.org/10.1101/2022.11.04.22281243
https://doi.org/10.1101/2022.11.04.22281243
Autor:
Ned Lewis, Shaun J. Grannis, Stephanie A. Irving, Eduardo Azziz-Baumgartner, Rachael M. Porter, Sarah Ball, Eric P. Griggs, Yan Zhuang, Matthew E Levy, Kristin Dascomb, Edward Stenehjem, Suchitra Rao, Maria Demarco, Jennifer R. Verani, Pat Shifflett, Ousseny Zerbo, Kristin Goddard, Malini B. DeSilva, Natalie Olson, Stephanie J. Schrag, Manjusha Gaglani, Catherine H Bozio, J.A Arndorfer, Lenee Blanton, Bruce Fireman, Allison L. Naleway, Mark G. Thompson, Karthik Natarajan, Michelle A. Barron, Nimish R. Valvi, Elizabeth A Rowley, Toan C. Ong, Nicola P. Klein, Nancy Grisel, Sue Reynolds, William F. Fadel, Palak Patel, Alicia M Fry, Jill M. Ferdinands, Brian E. Dixon, Jungmi Han, Elyse O. Kharbanda, Rebecca J. Birch, Andrea Steffens
Publikováno v:
The New England Journal of Medicine
Background There are limited data on the effectiveness of the vaccines against symptomatic coronavirus disease 2019 (Covid-19) currently authorized in the United States with respect to hospitalization, admission to an intensive care unit (ICU), or am